已收盘 10-31 16:00:00 美东时间
+0.050
+0.63%
- Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; potentially relevant in up to 5% of all solid tumors - Selective CBP
10-30 19:37
Agios Pharmaceuticals reported Q3 2025 financial results and updates, highlighting $12.9 million net revenue for PYRUKYND® (mitapivat), an increase of 44% YoY. The FDA extended the PDUFA goal date for PYRUKYND's sNDA in thalassemia to December 7, 2025, due to a request for a REMS program. The CHMP adopted a positive opinion for PYRUKYND in thalassemia, with an EC decision expected by early 2026. Topline RISE UP Phase 3 trial results in sickle cel...
10-30 10:30
—Insmed Leads Science Top Employers List for Fifth Year in a Row— BRIDGEWATER, N.J., Oct. 23, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical...
10-24 04:05
CAMBRIDGE, Mass., Oct. 20, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that two...
10-20 20:31
—Data on Structural Lung Changes from a High-Resolution CT Substudy to be Presented as Late-Breaker——Additional Analyses Will Highlight Efficacy, Symptom Reduction, and Biomarker Suppression in Patients with Non-Cystic
10-16 19:04
CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Pre...
10-14 20:31
10月9日晚8点,京东11.11盛大开启,为助力商家科学布局大促,京东基于BRIDGE数智品效解决方案进一步提炼,重磅推出——京东VALUE全域用户价值经营方法...
10-10 23:03
(来源:爱建证券研究所) 投资要点: 集成电路制造领涨电子行业。本周(2025/9/29-10/03)SW电子行业指数(+2.78%),涨跌幅排名6/3...
10-09 14:38
New LEQEMBI Companion™ program launched to expand helpful resources for patients throughout the treatment journey, including Nurse Educators who can provide patients with injection training, and an injection
10-07 04:34
CAMBRIDGE, Mass., Oct. 6, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe ...
10-06 21:00